Mutation Analysis of BRAF, MEK1 and MEK2 in 15 Ovarian Cancer Cell Lines: Implications for Therapy

Anne L. Estep(Cancer Research Institute), Katherine A. Rauen(Cancer Research Institute)
PLoS ONE
December 4, 2007
Cited by 94


Related Papers

Costello syndrome: Clinical phenotype, genotype, and management guidelines
|American Journal of Medical Genetics Part A|2019|127